RALEIGH, N.C. and COLUMBUS, Ohio, Sept 21 (Bernama) — PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new strategic relationship to accelerate patient access and recruitment for oncology clinical trials.
The relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer